Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mayur Ian Somaiya currently holds 115,000 shares of NewAmsterdam Pharma Co N.V. (NAMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mayur Ian Somaiya has been a net seller of NAMS stock. They have purchased $0 and sold $350.2K worth of shares.
Mayur Ian Somaiya's most recent insider trade was on Jan 7, 2026, when they sold 115,000 shares at $0.00 per share.
Mayur Ian Somaiya serves as Executive at NewAmsterdam Pharma Co N.V. (NAMS). They have executed 11 insider transactions totaling $350.2K over their tenure at the company.
Mayur Ian Somaiya holds the position of Executive at NewAmsterdam Pharma Co N.V., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Mayur Ian Somaiya has shown a selling trading pattern, with $0 in total purchases and $350.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mayur Ian Somaiya was on Jan 5, 2026, when they sold $170.2K worth of NAMS shares. This transaction involved 5,118 shares at $33.25 per share.
Mayur Ian Somaiya currently owns 115,000 shares of NewAmsterdam Pharma Co N.V. (NAMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mayur Ian Somaiya's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mayur Ian Somaiya has 11 Form 4 filings on record as an insider at NewAmsterdam Pharma Co N.V..
Set alerts for Mayur Ian Somaiya and 40,000+ other insiders.